EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pediatric psoriasis: from immunogenetics to targeted therapies

Adriana Schikiera Martinelli Salathiel, Elisa Nunes Secamilli, Marina Gagheggi Maciel, Juliana Yumi Massuda Serrano, Andrea Fernandes Eloy da Costa França, Renata Ferreira Magalhães

Anais Brasileiros de Dermatologia · 2026-07 · 101 (4) · 501413

DOI: 10.1016/j.abd.2026.501413 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Anais Brasileiros de Dermatologia, 2026-07. Verfasst von Adriana Schikiera Martinelli Salathiel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Dermatology, Pediatric Dermatology Outpatient Clinic, Hospital das Clínicas, Universidade Estadual de Ca…. Hauptthemen laut MEDLINE: Psoriasis. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pediatric psoriasis may result in significant cumulative life course impairment, and there is comparatively less evidence available than for adult psoriasis.

Objective

The aim of this study is to provide an update on the management of pediatric psoriasis, integrating recent immunogenetic and therapeutic advances. It highlights challenges, including clinical heterogeneity, complex differential diagnosis, and limited treatment options, especially in Brazil.

Methods

A narrative review was conducted, including studies published in English, Portuguese, and Spanish between 2009 and 2025, retrieved from the United States National Library of Medicine (PubMed), Cochrane Library, and Scientific Electronic Library Online (SciELO). The following descriptors were used: ‘‘psoriasis’’, ‘‘child health’’, ‘‘pediatrics’’, ‘‘therapeutics’’, ‘‘comorbidity’’, and ‘‘T-lymphocyte antigen differentiation’’.

Results

Pediatric psoriasis most commonly presents as chronic plaque. Differential diagnoses are broad and include atopic dermatitis and autoimmune diseases. Data about comorbidities, particularly cardiovascular risk, are controversial. Although severe cases are less frequent, they are associated with a substantial impact on quality of life. Conventional therapies include topical corticosteroids, phototherapy, and non-targeted systemic agents such as acitretin, methotrexate, and cyclosporine. Biologic therapies have been approved for pediatric use and demonstrate safety profiles and superior efficacy compared to conventional treatments. Study limitations: Scarcity of pediatric psoriasis guidelines.

Conclusions

Despite advances in understanding adult psoriasis, evidence in pediatric popu-lations remains limited, especially in Brazil. Expanding knowledge in pediatric psoriasis is essential to improve diagnosis, optimize treatment strategies, and increase access to innovative therapies, thereby reducing inflammatory burden and cumulative life course impairment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisHumansChildImmunogeneticsDiagnosis, DifferentialBrazilDermatologic AgentsPhototherapy

Stichwörter der Autor:innen

AntigensChild healthComorbidityDifferentiationPediatricsPsoriasisT-LymphocyteTherapeutics

Substanzen

Dermatologic Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Dermatology, Pediatric Dermatology Outpatient Clinic, Hospital das Clínicas, Universidade Estadual de Campinas, Campinas, SP, Brazil. Electronic address: adrianasmsalathiel@g…
  • Department of Internal Medicine, Division of Dermatology, Pediatric Dermatology Outpatient Clinic, Hospital das Clínicas, Universidade Estadual de Campinas, Campinas, SP, Brazil.
  • Department of Internal Medicine, Dermatology Division, Psoriasis Outpatient Clinic, Hospital das Clínicas, Universidade Estadual de Campinas, Campinas, SP, Brazil.
  • Department of Internal Medicine, Dermatology Division, Pediatric Psoriasis and Dermatology Outpatient Clinic, Hospital das Clínicas, Universidade Estadual de Campinas, Campinas, SP, Brazil.

Zitieren

APA

Martinelli Salathiel, A. S., Secamilli, E. N., Maciel, M. G., Serrano, J. Y. M., da Costa França, A. F. E., & Magalhães, R. F. (2026). Pediatric psoriasis: from immunogenetics to targeted therapies. Anais Brasileiros de Dermatologia, 101(4), 501413. https://doi.org/10.1016/j.abd.2026.501413

Vancouver

Martinelli Salathiel AS, Secamilli EN, Maciel MG, Serrano JYM, da Costa França AFE, Magalhães RF. Pediatric psoriasis: from immunogenetics to targeted therapies. Anais Brasileiros de Dermatologia. 2026;101(4):501413. doi:10.1016/j.abd.2026.501413

BibTeX
@article{MartinelliSalathiel2026,
  author = {Martinelli Salathiel, Adriana Schikiera and Secamilli, Elisa Nunes and Maciel, Marina Gagheggi and Serrano, Juliana Yumi Massuda and da Costa França, Andrea Fernandes Eloy and Magalhães, Renata Ferreira},
  title = {Pediatric psoriasis: from immunogenetics to targeted therapies},
  journal = {Anais Brasileiros de Dermatologia},
  year = {2026},
  volume = {101},
  number = {4},
  pages = {501413},
  doi = {10.1016/j.abd.2026.501413}
}
Kostenlos starten →